13F HOLDINGS REPORT
BIOIMPACT CAPITAL LLC
Quarter ended Q2 2023 · Filed May 12, 2023 · Accession 0000950123-23-004668
Total Value
$384.9M
Positions
31
Other Managers
0
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cullinan Oncology, Inc. | CGEM | 7,648,268 | $78.2M | 20.33% |
| 2 | Provention Bio Inc | 74374N102 | 1,173,809 | $28.3M | 7.35% |
| 3 | Iveric Bio Inc | 46583P102 | 1,045,691 | $25.4M | 6.61% |
| 4 | iTeos Therapeutics, Inc. | 46565G104 | 1,745,943 | $23.8M | 6.17% |
| 5 | Inhibrx, Inc Com | INBX | 1,192,281 | $22.5M | 5.84% |
| 6 | Intellia Therapeutics, Inc. | NTLA | 572,459 | $21.3M | 5.54% |
| 7 | Relay Therapeutics Inc. | RLAY | 1,225,634 | $20.2M | 5.24% |
| 8 | Geron Corporation | GERN | 8,401,565 | $18.2M | 4.74% |
| 9 | Reata Pharmaceuticals inc-a | 75615P103 | 176,874 | $16.5M | 4.30% |
| 10 | Repare Therapeutics, Inc. | 760273102 | 1,639,849 | $16.1M | 4.19% |
| 11 | Iovance Biotherapeutics Inc Com | IOVA | 2,614,977 | $16.0M | 4.15% |
| 12 | REGENXBIO Inc. | RGNX | 617,671 | $11.7M | 3.03% |
| 13 | Verve Therapeutics, Inc | 92539P101 | 803,501 | $11.6M | 3.01% |
| 14 | Madrigal Pharmaceuticals inc | MDGL | 36,038 | $8.7M | 2.27% |
| 15 | Travere Therapeutics Inc. | TVTX | 313,642 | $7.1M | 1.83% |
| 16 | Uniqure N.V. | QURE | 348,224 | $7.0M | 1.82% |
| 17 | Insmed Incorporated | INSM | 399,192 | $6.8M | 1.77% |
| 18 | Werewolf Therapeutics, Inc. | HOWL | 2,388,011 | $6.2M | 1.61% |
| 19 | Crinetics Pharmaceuticals Inc. | CRNX | 360,392 | $5.8M | 1.50% |
| 20 | Revolution Medicines, Inc. | RVMDW | 247,022 | $5.4M | 1.39% |
| 21 | TCR2 Therapeutics, Inc. | 87808K106 | 3,370,982 | $5.1M | 1.31% |
| 22 | Chinook Therapeutics, Inc. | 16961L106 | 197,806 | $4.6M | 1.19% |
| 23 | Axsome Therapeutics, Inc. | AXSM | 70,402 | $4.3M | 1.13% |
| 24 | Amicus Therapeutics Inc. | FOLD | 388,292 | $4.3M | 1.12% |
| 25 | Arcutis Biotherapeutics inc | ARQT | 254,137 | $2.8M | 0.73% |
| 26 | Harpoon Therapeutics, Inc. | 41358P106 | 3,196,707 | $2.4M | 0.62% |
| 27 | Phathom Pharmaceuticals inc | PHAT | 212,615 | $1.5M | 0.39% |
| 28 | Inozyme Pharma Inc. | 45790W108 | 233,728 | $1.3M | 0.35% |
| 29 | Oncorus, Inc. | 68236R103 | 2,377,031 | $817,699 | 0.21% |
| 30 | AVROBIO, Inc. | 05455M100 | 647,918 | $647,918 | 0.17% |
| 31 | Black Diamond Therapeutics, Inc. | BDTX | 144,888 | $273,838 | 0.07% |